CaMKII in cerebral ischemia

Acta Pharmacologica Sinica

Volumn 32, Issue 7, 2011, Pages 861-872

  Coultrap, Steven J ^a   Vest, Rebekah S ^a   Ashpole, Nicole M ^b   Hudmon, Andy ^b,c   Bayer, K Ulrich ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

brain ischemia; CaM kinases; CaMKII; excitotoxicity; glutamate; stroke

Indexed keywords

2 [1 CARBOXY 2 [4 [2 (5 METHYL 2 PHENYL 4 OXAZOLYL)ETHOXY]PHENYL]ETHYLAMINO]BENZOIC ACID METHYL ESTER; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; GLUTAMIC ACID; PROTEIN SERINE THREONINE KINASE INHIBITOR;

BRAIN ISCHEMIA; CELL DEATH; DOWNSTREAM PROCESSING; ENZYME REGULATION; EXCITOTOXICITY; HUMAN; NERVE CELL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; BRAIN; BRAIN ISCHEMIA; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; GLUTAMIC ACID; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEUROPROTECTIVE AGENTS; PROTEIN KINASE INHIBITORS;

EID: 79960039268     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.68     Document Type: Review

References (211)

1. Liu S, Levine SR, Winn HR. Targeting ischemic penumbra: part I - from pathophysiology to therapeutic strategy. J Exp Stroke Transl Med 2010; 3: 47-55.
2. Weinberger JM. Evolving therapeutic approaches to treating acute ischemic stroke. J Neurol Sci 2006; 249: 101-9. (Pubitemid 44665917)
3. Kaur J, Zhao Z, Klein GM, Lo EH, Buchan AM. The neurotoxicity of tissue plasminogen activator? J Cereb Blood Flow Metab 2004; 24: 945-63. (Pubitemid 39223619)
4. Wang X, Tsuji K, Lee SR, Ning M, Furie KL, Buchan AM, et al. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke 2004; 35: 2726-30. (Pubitemid 39458380)
5. Kleindorfer D, Lindsell CJ, Brass L, Koroshetz W, Broderick JP. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke 2008; 39: 924-8. (Pubitemid 351619542)
6. Vest RS, OLeary H, Coultrap SJ, Kindy MS, Bayer KU. Effective post- insult neuroprotection by a novel Ca2+/calmodulin-dependent protein kinase II (CaMKII) inhibitor. J Biol Chem 2010; 285: 20675-82.
7. Ashpole NM, Hudmon A. Excitotoxic neuroprotection and vulnerability with CaMKII inhibition. Mol Cell Neurosci 2011; 46: 720-30.
8. Choi DW. Ionic dependence of glutamate neurotoxicity. J Neurosci 1987; 7: 369-79. (Pubitemid 17017466)
9. Lucas DR, Newhouse JP. The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Arch Ophthalmol 1957; 58: 193-201.
10. Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969; 164: 719-21.
11. Olney JW, Sharpe LG. Brain lesions in an infant rhesus monkey treated with monsodium glutamate. Science 1969; 166: 386-8.
12. Hubschmann OR, Kornhauser D. Cortical cellular response in acute subarachnoid hemorrhage. J Neurosurgery 1980; 52: 456-62. (Pubitemid 10130633)
13. Doyle KP, Simon RP, Stenzel-Poore MP. Mechanisms of ischemic brain damage. Neuropharmacology 2008; 55: 310-8.
14. Hara MR, Snyder SH. Cell signaling and neuronal death. Annu Rev Pharmacol Toxicol 2007; 47: 117-41.
15. Aarts MM, Tymianski M. Molecular mechanisms underlying specificity of excitotoxic signaling in neurons. Curr Mol Med 2004; 4: 137-47. (Pubitemid 38425911)
16. Bramlett HM, Dietrich WD. Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J Cereb Blood Flow Metab 2004; 24: 133-50. (Pubitemid 38199107)
17. Greve MW, Zink BJ. Pathophysiology of traumatic brain injury. Mount Sinai Journal of Medicine: J Translation Personalized Med 2009; 76: 97-104.
18. Mattson MP. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med 2003; 3: 65-94. (Pubitemid 37012494)
19. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995; 15: 961-73.
20. McDonald JW, Behrens MI, Chung C, Bhattacharyya T, Choi DW. Susceptibility to apoptosis is enhanced in immature cortical neurons. Brain Res 1997; 759: 228-232. (Pubitemid 27286699)
21. Yuan J, Lipinski M, Degterev A. Diversity in the mechanisms of neuronal cell death. Neuron 2003; 40: 401-13. (Pubitemid 37244104)
22. Broughton BRS, Reutens DC, Sobey CG. Apoptotic mechanisms after cerebral ischemia. Stroke 2009; 40: e331-9.
23. Choi DW, Koh JY, Peters S. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J Neurosci 1988; 8: 185-96. (Pubitemid 18038308)
24. Frandsen A, Drejer J, Schousboe A. Direct evidence that excitotoxicity in cultured neurons is mediated via N-methyl-D-aspartate (NMDA) as well as non-NMDA receptors. J Neurochem 1989; 53: 297-9. (Pubitemid 19158142)
25. Noh KM, Yokota H, Mashiko T, Castillo PE, Zukin RS, Bennett MV. Blockade of calcium-permeable AMPA receptors protects hippocampal neurons against global ischemia-induced death. Proc Natl Acad Sci U S A 2005; 102: 12230-5. (Pubitemid 41291157)
26. Aarts M, Liu Y, Liu L, Besshoh S, Arundine M, Gurd JW, et al. Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. Science 2002; 298: 846-50. (Pubitemid 35231541)
27. Ginsberg MD. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 2008; 55: 363-89.
28. Villmann C, Becker CM. On the hypes and falls in neuroprotection: targeting the NMDA receptor. Neuroscientist 2007; 13: 594-615. (Pubitemid 350077310)
29. Malenka RC, Nicoll RA. Long-term potentiation - a decade of progress? Science 1999; 285: 1870-4.
30. Lisman J, Schulman H, Cline H. The molecular basis of CaMKII function in synaptic and behavioural memory. Nat Rev Neurosci 2002; 3: 175-90. (Pubitemid 135706588)
31. Hudmon A, Schulman H. Neuronal Ca2+/calmodulin-dependent protein kinase II: the role of structure and autoregulation in cellular function. Annu Rev Biochem 2002; 71: 473-510. (Pubitemid 34800228)
32. Ryazanov AG, Ward MD, Mendola CE, Pavur KS, Dorovkov MV, Wiedmann M, et al. Identification of a new class of protein kinases represented by eukaryotic elongation factor-2 kinase. Proc Natl Acad Sci U S A 1997; 94: 4884-9. (Pubitemid 27214705)
33. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science 2002; 298: 1912-34. (Pubitemid 35425239)
34. Haribabu B, Hook SS, Selbert MA, Goldstein EG, Tomhave ED , Edelman AM, et al. Human calcium-calmodulin dependent protein kinase I: cDNA cloning, domain structure and activation by phosphorylation at threonine-177 by calcium-calmodulin dependent protein kinase I kinase. EMBO J 1995; 14: 3679-86.
35. Miller SG, Kennedy MB. Regulation of brain type II Ca2+/ calmodulindependent protein kinase by autophosphorylation: a Ca2+-triggered molecular switch. Cell 1986; 44: 861-70. (Pubitemid 16045332)
36. Lou LL, Lloyd SJ, Schulman H. Activation of the multifunctional Ca2+/ calmodulin-dependent protein kinase by autophosphorylation: ATP modulates production of an autonomous enzyme. Proc Natl Acad Sci U S A 1986; 83: 9497-501. (Pubitemid 17223387)
37. Schworer CM, Colbran RJ, Soderling TR. Reversible generation of a Ca2+-independent form of Ca2+(calmodulin)-dependent protein kinase II by an autophosphorylation mechanism. J Biol Chem 1986; 261: 8581-4. (Pubitemid 17205046)
38. Kolodziej SJ, Hudmon A, Waxham MN, Stoops JK. Three-dimensional reconstructions of calcium/calmodulin-dependent (CaM) kinase II and truncated CaM kinase II reveal a unique organization for its structural core and functional domains. J Biol Chem 2000; 275: 14354-9. (Pubitemid 30339718)
39. Chen CH, Wang WJ, Kuo JC, Tsai HC, Lin JR, Chang ZF. Bidirectional signals transduced by DAPK-ER K interaction promote the apoptotic effect of DAPK. EMBO J 2005; 24: 294-304.
40. Bialik S, Kimchi A. The death-associated protein kinases: structure, function, and beyond. Annu Rev Biochem 2006; 75: 189-210. (Pubitemid 44118031)
41. Stull JT, Lin PJ, Krueger JK, Trewhella J, Zhi G. Myosin light chain kinase: functional domains and structural motifs. Acta Physiol Scand 1998; 164: 471-82. (Pubitemid 29015666)
42. Oakhill JS, Scott JW, Kemp BE. Structure and function of AMPactivated protein kinase. Acta Physiol 2009; 196: 3-14.
43. Wayman GA, Lee YS, Tokumitsu H, Silva A, Soderling TR. Calmodulinkinases: modulators of neuronal development and plasticity. Neuron 2008; 59: 914-31.
44. Tobimatsu T, Fujisawa H. Tissue-specific expression of four types of rat calmodulin-dependent protein kinase II mRNAs. J Biol Chem 1989; 264: 17907-12. (Pubitemid 19279256)
45. Bayer KU, Lohler J, Schulman H, Harbers K. Developmental expression of the CaM kinase II isoforms: ubiquitous gamma- and delta- CaM kinase II are the early isoforms and most abundant in the developing nervous system. Brain Res Mol Brain Res 1999; 70: 147-54. (Pubitemid 29278617)
46. Erondu NE, Kennedy MB. Regional distribution of type II Ca2+/ calmodulin-dependent protein kinase in rat brain. J Neurosci 1985; 5: 3270-7. (Pubitemid 16182607)
47. Hatakeyama T, Matsumoto M, Brengman J, Yanagihara T. Immunohistochemical investigation of ischemic and postischemic damage after bilateral carotid occlusion in gerbils. Stroke 1988; 19: 1526-34. (Pubitemid 19005809)
48. Silva AJ, Stevens CF, Tonegawa S, Wang Y. Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice. Science 1992; 257: 201-6.
49. Silva AJ, Paylor R, Wehner JM, Tonegawa S. Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice. Science 1992; 257: 206-11.
50. Hoelz A, Nairn AC, Kuriyan J. Crystal structure of a tetradecameric assembly of the association domain of Ca2+/calmodulin-dependent kinase II. Mol Cell 2003; 11: 1241-51. (Pubitemid 36645143)
51. Rosenberg OS, Deindl S, Sung RJ, Nairn AC, Kuriyan J. Structure of the autoinhibited kinase domain of CaMKII and SAXS analysis of the holoenzyme. Cell 2005; 123: 849-60. (Pubitemid 41721031)
52. Rosenberg OS, Deindl S, Comolli LR , Hoelz A, Downing KH, Nairn AC, et al. Oligomerization states of the association domain and the holoenyzme of Ca/CaM kinase II. FEBS J 2006; 273: 682-94.
53. Rellos P, Pike AC, Niesen FH, Salah E, Lee WH, von Delft F, et al. Structure of the CaMKIIdelta/calmodulin complex reveals the molecular mechanism of CaMKII kinase activation. PLoS Biol 2010; 8: e1000426.
54. Bayer KU, Harbers K, Schulman H. alphaKAP is an anchoring protein for a novel CaM kinase II isoform in skeletal muscle. EMBO J 1998; 17: 5598-605. (Pubitemid 28445971)
55. Schulman H, Greengard P. Stimulation of brain membrane protein phosphorylation by calcium and an endogenous heat-stable protein. Nature 1978; 271: 478-9. (Pubitemid 8257927)
56. Bennett MK, Erondu NE, Kennedy MB. Purification and characterization of a calmodulin-dependent protein kinase that is highly concentrated in brain. J Biol Chem 1983; 258: 12735-44. (Pubitemid 14231188)
57. Yamauchi T, Ohsako S, Deguchi T. Expression and characterization of calmodulin-dependent protein kinase II from cloned cDNAs in Chinese hamster ovary cells. J Biol Chem 1989; 264: 19108-16. (Pubitemid 19285818)
58. Kolb SJ, Hudmon A, Ginsberg TR , Waxham MN. Identification of domains essential for the assembly of calcium/calmodulin-dependent protein kinase II holoenzymes. J Biol Chem 1998; 273: 31555-64. (Pubitemid 28533179)
59. Brocke L, Chiang LW, Wagner PD, Schulman H. Functional implications of the subunit composition of neuronal CaM kinase II. J Biol Chem 1999; 274: 22713-22.
60. Lantsman K, Tombes RM. CaMK-II oligomerization potential determined using CFP/YFP FRET . Biochim Biophys Acta 2005; 1746: 45-54. (Pubitemid 41484085)
61. Kanaseki T, Ikeuchi Y, Sugiura H, Yamauchi T. Structural features of Ca2+/calmodulin-dependent protein kinase II revealed by electron microscopy. J Cell Biol 1991; 115: 1049-60. (Pubitemid 21909952)
62. Morris EP, Török K. Oligomeric structure of [alpha]-calmodulindependent protein kinase II. J Mol Biol 2001; 308: 1-8. (Pubitemid 33027621)
63. Yang E, Schulman H. Structural examination of autoregulation of multifunctional calcium/calmodulin-dependent protein kinase II. J Biol Chem 1999; 274: 26199-208.
64. Bayer KU, De Koninck P, Leonard AS, Hell JW, Schulman H. Interaction with the NMDA receptor locks CaMKII in an active conformation. Nature 2001; 411: 801-5. (Pubitemid 32588103)
65. Hanson PI, Meyer T, Stryer L, Schulman H. Dual role of calmodulin in autophosphorylation of multifunctional CaM kinase may underlie decoding of calcium signals. Neuron 1994; 12: 943-56. (Pubitemid 24178190)
66. Rich RC, Schulman H. Substrate-directed function of calmodulin in autophosphorylation of Ca2+/calmodulin-dependent protein kinase II. J Biol Chem 1998; 273: 28424-9. (Pubitemid 28496147)
67. Coultrap SJ, Buard I, Kulbe JR, DellAcqua ML, Bayer KU. CaMKII autonomy is substrate-dependent and further stimulated by Ca2+/ calmodulin. J Biol Chem 2010; 285: 17930-7.
68. Giese KP, Fedorov NB, Filipkowski RK, Silva AJ. Autophosphorylation at Thr286 of the alpha calcium-calmodulin kinase II in LT P and learning. Science 1998; 279: 870-3. (Pubitemid 28106282)
69. Colbran RJ, Soderling TR . Calcium/calmodulin-independent autophosphorylation sites of calcium/calmodulin-dependent protein kinase II. Studies on the effect of phosphorylation of threonine 305/306 and serine 314 on calmodulin binding using synthetic peptides. J Biol Chem 1990; 265: 11213-9.
70. Hanson PI, Schulman H. Inhibitory autophosphorylation of multifunctional Ca2+/calmodulin-dependent protein kinase analyzed by sitedirected mutagenesis. J Biol Chem 1992; 267: 17216-24.
71. Colbran RJ. Inactivation of Ca2+/calmodulin-dependent protein kinase II by basal autophosphorylation. J Biol Chem 1993; 268: 7163-70. (Pubitemid 23105606)
72. Lu CS, Hodge JJ, Mehren J, Sun XX, Griffith LC. Regulation of the Ca2+/CaM-responsive pool of CaMKII by scaffold-dependent autophosphorylation. Neuron 2003; 40: 1185-97. (Pubitemid 38032794)
73. Malinow R, Schulman H, Tsien RW. Inhibition of postsynaptic PKC or CaMKII blocks induction but not expression of LT P. Science 1989; 245: 862-6. (Pubitemid 19223665)
74. Buard I, Coultrap SJ, Freund RK, Lee YS, DellAcqua ML, Silva AJ, et al. CaMKII "autonomy" is required for initiating but not for maintaining neuronal long-term information storage. J Neurosci 2010; 30: 8214-20.
75. Lee YS, Silva AJ. The molecular and cellular biology of enhanced cognition. Nat Rev Neurosci 2009; 10: 126-40.
76. Shen K, Meyer T. Dynamic control of CaMKII translocation and localization in hippocampal neurons by NMDA receptor stimulation. Science 1999; 284: 162-6. (Pubitemid 29282073)
77. Otmakhov N, Tao-Cheng JH, Carpenter S, Asrican B, Dosemeci A, Reese TS, et al. Persistent accumulation of calcium/calmodulindependent protein kinase II in dendritic spines after induction of NMDA receptor-dependent chemical long-term potentiation. J Neurosci 2004; 24: 9324-31. (Pubitemid 39426169)
78. Bayer KU, LeBel E, McDonald GL, OLeary H, Schulman H, De Koninck H, et al. Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B. J Neurosci 2006; 26: 1164-74. (Pubitemid 43237049)
79. Hudmon A, Aronowski J, Kolb SJ, Waxham MN. Inactivation and selfassociation of Ca2+/calmodulin-dependent protein kinase II during autophosphorylation. J Biol Chem 1996; 271: 8800-8.
80. Dosemeci A, Reese TS, Petersen J, Tao-Cheng JH. A novel particulate form of Ca2+/CaMKII-dependent protein kinase II in neurons. J Neurosci 2000; 20: 3076-84. (Pubitemid 30263124)
81. Tao-Cheng JH, Vinade L, Smith C, Winters CA, Ward R, Brightman MW, et al. Sustained elevation of calcium induces Ca2+/calmodulindependent protein kinase II clusters in hippocampal neurons. Neuroscience 2001; 106: 69-78. (Pubitemid 32831074)
82. Hudmon A, Lebel E, Roy H, Sik A, Schulman H, Waxham MN, et al. A mechanism for Ca2+/calmodulin-dependent protein kinase II clustering at synaptic and nonsynaptic sites based on self-association. J Neurosci 2005; 25: 6971-83. (Pubitemid 41077005)
83. Barria A, Malinow R. NMDA receptor subunit composition controls synaptic plasticity by regulating binding to CaMKII. Neuron 2005; 48: 289-301. (Pubitemid 41476362)
84. Zhou Y, Takahashi E, Li W, Halt A, Wiltgen B, Ehninger D, et al. Interactions between the NR2B receptor and CaMKII modulate synaptic plasticity and spatial learning. J Neurosci 2007; 27: 13843-53. (Pubitemid 350278268)
85. Strack S, Colbran RJ. Autophosphorylation-dependent targeting of calcium/calmodulin-dependent protein kinase II by the NR2B subunit of the N-methyl-D-aspartate receptor. J Biol Chem 1998; 273: 20689-92. (Pubitemid 28385342)
86. Leonard AS, Bayer KU, Merrill MA, Lim IA, Shea MA, Schulman H, et al. Regulation of calcium/calmodulin-dependent protein kinase II docking to N-methyl-D-aspartate receptors by calcium/calmodulin and alpha-actinin. J Biol Chem 2002; 277: 48441-8. (Pubitemid 35470802)
87. Bayer KU, Schulman H. Regulation of signal transduction by protein targeting: the case for CaMKII. Biochem Biophys Res Commun 2001; 289: 917-23. (Pubitemid 34076276)
88. Colbran RJ, Brown AM. Calcium/calmodulin-dependent protein kinase II and synaptic plasticity. Curr Opin Neurobiol 2004; 14: 318-27. (Pubitemid 38759862)
89. Merrill MA, Chen Y, Strack S, Hell JW. Activity-driven postsynaptic translocation of CaMKII. Trends Pharmacol Sci 2005; 26: 645-53. (Pubitemid 41636310)
90. Hudmon A, Kim SA, Kolb SJ, Stoops JK, Waxham MN. Light scattering and transmission electron microscopy studies reveal a mechanism for calcium/calmodulin-dependent protein kinase II self-association. J Neurochem 2001; 76: 1364-75. (Pubitemid 32198241)
91. Vest RS, OLeary H, Bayer KU. Differential regulation by ATP versus ADP further links CaMKII aggregation to ischemic conditions. FEBS Lett 2009; 583: 3577-81.
92. Strack S, McNeill RB, Colbran RJ. Mechanism and regulation of calcium/calmodulin-dependent protein kinase II targeting to the NR2B subunit of the N-methyl-D-aspartate receptor. J Biol Chem 2000; 275: 23798-806. (Pubitemid 30624665)
93. Aronowski J, Grotta JC, Waxham MN. Ischemia-induced translocation of Ca2+/calmodulin-dependent protein kinase II: potential role in neuronal damage. J Neurochem 1992; 58: 1743-53.
94. Westgate SA, Brown J, Aronowski J, Waxham MN. Activity of Ca2+/ calmodulin-dependent protein kinase II following ischemia: a comparison between CA1 and dentate gyrus in a hippocampal slice model. J Neurochem 1994; 63: 2217-24.
95. Churn S, Limbrick D, Sombati S, DeLorenzo R. Excitotoxic activation of the NMDA receptor results in inhibition of calcium/calmodulin kinase II activity in cultured hippocampal neurons. J Neurosci 1995; 15: 3200-14.
96. Tokumitsu H, Chijiwa T, Hagiwara M, Mizutani A, Terasawa M, Hidaka H. KN-62,1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4- phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II. J Biol Chem 1990; 265: 4315-20.
97. Sumi M, Kiuchi K, Ishikawa T, Ishii A, Hagiwara M, Nagatsu T, et al. The newly synthesized selective Ca2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells. Biochem Biophys Res Commun 1991; 181: 968-75.
98. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000; 351: 95-105.
99. Enslen H, Sun P, Brickey D, Soderling SH, Klamo E, Soderling TR . Characterization of Ca2+/calmodulin-dependent protein kinase IV. Role in transcriptional regulation. J Biol Chem 1994; 269: 15520-7.
100. DellAcqua ML, Scott JD. Protein kinase A anchoring. J Biol Chem 1997 272 12881-4. (Pubitemid 27216698)
101. Brooks IM, Tavalin SJ. CaMKII inhibitors disrupt AKAP79-dependent PKC signaling to GluA1 AMPA receptors. J Biol Chem 2011; 286: 6697-706.
102. L i G, Hidaka H, Wollheim CB. Inhibition of voltage-gated Ca2+ channels and insulin secretion in HIT cells by the Ca2+/calmodulindependent protein kinase II inhibitor KN-62: comparison with antagonists of calmodulin and L-type Ca2+ channels. Mol Pharmacol 1992; 42: 489-8.
103. Ledoux J, Chartier D, Leblanc N. Inhibitors of calmodulin-dependent protein kinase are nonspecific blockers of voltage-dependent K+ channels in vascular myocytes. J Pharmacol Exp Ther 1999 290 1165-74. (Pubitemid 29400257)
104. Ishida A, Kameshita I, Okuno S, Kitani T, Fujisawa H. A novel highly specific and potent inhibitor of calmodulin-dependent protein kinase II. Biochem Biophys Res Commun 1995; 212: 806-12.
105. Patel R, Holt M, Philipova R, Moss S, Schulman H, Hidaka H, et al. Calcium/calmodulin-dependent phosphorylation and activation of human Cdc25-C at the G2/M phase transition in HeLa cells. J Biol Chem 1999; 274: 7958-68.
106. H valby O, Hemmings HC Jr, Paulsen O, Czernik AJ, Nairn AC, Godfraind JM, et al. Specificity of protein kinase inhibitor peptides and induction of long-term potentiation. Proc Natl Acad Sci U S A 1994; 91: 4761-5.
107. Smith MK, Colbran RJ, Soderling TR. Specificities of autoinhibitory domain peptides for four protein kinases. Implications for intact cell studies of protein kinase function. J Biol Chem 1990; 265: 1837-40.
108. Backs J, Backs T, Neef S, Kreusser MM, Lehmann LH , Patrick DM, et al. The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc Natl Acad Sci U S A 2009; 106: 2342-7.
109. Patel R, Holt M, Philipova R, Moss S, Schulman H, Hidaka H, et al. Calcium/calmodulin-dependent phosphorylation and activation of human Cdc25-C at the G2/M phase transition in HeLa cells. J Biol Chem 1999; 274: 7958-68.
110. Chen HX, Otmakhov N, Strack S, Colbran RJ, Lisman JE. Is persistent activity of calcium/calmodulin-dependent kinase required for the maintenance of LT P? J Neurophysiol 2001; 85: 1368-76. (Pubitemid 32280578)
111. Vest RS, Davies KD, OLeary H, Port JD, Bayer KU. Dual mechanism of a natural CaMKII inhibitor. Mol Biol Cell 2007; 18: 5024-33. (Pubitemid 350246702)
112. Chang BH, Mukherji S, Soderling TR . Characterization of a calmodulin kinase II inhibitor protein in brain. Proc Natl Acad Sci U S A 1998; 95: 10890-5. (Pubitemid 28413164)
113. Schwartz JJ, Zhang S. Peptide-mediated cellular delivery. Curr Opin Mol Ther 2000; 2: 162-7. (Pubitemid 30212265)
114. Green I, Christison R, Voyce CJ, Bundell KR, Lindsay MA. Protein transduction domains: are they delivering? Trends Pharmacol Sci 2003; 24: 213-5. (Pubitemid 36588865)
115. Joliot A, Prochiantz A. Transduction peptides: from technology to physiology. Nat Cell Biol 2004; 6: 189-96. (Pubitemid 38344356)
116. Fink CC, Bayer KU, Myers JW, Ferrell JE Jr, Schulman H, Meyer T. Selective regulation of neurite extension and synapse formation by the beta but not the alpha isoform of CaMKII. Neuron 2003; 39: 283-97. (Pubitemid 36897550)
117. Illario M, Cavallo AL, Bayer KU, Di Matola T, Fenzi G, Rossi G, et al. Calcium/calmodulin-dependent protein kinase II binds to Raf-1 and modulates integrin-stimulated ER K activation. J Biol Chem 2003; 278: 45101-8. (Pubitemid 37432642)
118. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999; 285: 1569-72. (Pubitemid 29420581)
119. H ajimohammadreza I, Probert AW, Coughenour LL , Borosky SA, Marcoux FW, Boxer PA, et al. A specific inhibitor of calcium/ calmodulin-dependent protein kinase-II provides neuroprotection against NMDA- and hypoxia/hypoglycemia- induced cell death. J Neurosci 1995; 15: 4093-101.
120. L aabich A, Cooper NG. Neuroprotective effect of AIP on N-methyl-Daspartate- induced cell death in retinal neurons. Brain Res Mol Brain Res 2000; 85: 32-40. (Pubitemid 32063059)
121. Takano H, Fukushi H, Morishima Y, Shirasaki Y. Calmodulin and calmodulin-dependent kinase II mediate neuronal cell death induced by depolarization. Brain Res 2003 962 41-7. (Pubitemid 36126320)
122. Fan W, Agarwal N, Cooper NG. The role of CaMKII in BDNF-mediated neuroprotection of retinal ganglion cells (RGC-5). Brain Res 2006; 1067: 48-57. (Pubitemid 43133073)
123. Gao J, Duan B, Wang DG, Deng XH, Zhang GY, Xu L, et al. Coupling between NMDA receptor and acid-sensing ion channel contributes to ischemic neuronal death. Neuron 2005; 48: 635-46. (Pubitemid 41654684)
124. Waxham MN, Grotta JC, Silva AJ, Strong R, Aronowski J. Ischemiainduced neuronal damage: a role for calcium/calmodulin-dependent protein kinase II. J Cereb Blood Flow Metab 1996; 16: 1-6. (Pubitemid 26007946)
125. Mabuchi T, Kitagawa K, Kuwabara K, Takasawa K, Ohtsuki T, Xia Z, et al. Phosphorylation of cAMP response element-binding protein in hippocampal neurons as a protective response after exposure to glutamate in vitro and ischemia in vivo. J Neurosci 2001; 21: 9204-13. (Pubitemid 33096864)
126. L inseman DA, Bartley CM, Le SS, Laessig TA, Bouchard RJ, Meintzer MK, et al. Inactivation of the myocyte enhancer factor-2 repressor histone deacetylase-5 by endogenous Ca2+/calmodulin-dependent kinase II promotes depolarization-mediated cerebellar granule neuron survival. J Biol Chem 2003; 278: 41472-81. (Pubitemid 37280976)
127. Bok J, Wang Q, Huang J, Green SH. CaMKII and CaMKIV mediate distinct prosurvival signaling pathways in response to depolarization in neurons. Mol Cell Neurosci 2007; 36: 13-26. (Pubitemid 47379552)
128. H ansen MR, Bok J, Devaiah AK, Zha XM, Green SH. Ca2+/calmodulindependent protein kinases II and IV both promote survival but differ in their effects on axon growth in spiral ganglion neurons. J Neurosci Res 2003; 72: 169-84. (Pubitemid 36389883)
129. Butler LS, Silva AJ, Abeliovich A, Watanabe Y, Tonegawa S, McNamara JO. Limbic epilepsy in transgenic mice carrying a Ca2+/calmodulindependent kinase II alpha-subunit mutation. Proc Natl Acad Sci U S A 1995; 92: 6852-5.
130. Y amagata Y, Kobayashi S, Umeda T, Inoue A, Sakagami H, Fukaya M, et al. Kinase-dead knock-in mouse reveals an essential role of kinase activity of Ca2+/calmodulin-dependent protein kinase II{alpha} in dendritic spine enlargement, long-term potentiation, and learning. J Neurosci 2009; 29: 7607-18.
131. Finkbeiner S, Tavazoie SF, Maloratsky A, Jacobs KM, Harris KM, Greenberg ME. CRE B: a major mediator of neuronal neurotrophin responses. Neuron 1997; 19: 1031-47. (Pubitemid 27512364)
132. See V, Boutillier AL, Bito H, Loeffler JP. Calcium/calmodulindependent protein kinase type IV (CaMKIV) inhibits apoptosis induced by potassium deprivation in cerebellar granule neurons. FASEB J 2001; 15: 134-44. (Pubitemid 32061664)
133. Wu GY, Deisseroth K, Tsien RW. Activity-dependent CRE B phosphorylation: convergence of a fast, sensitive calmodulin kinase pathway and a slow, less sensitive mitogen-activated protein kinase pathway. Proc Natl Acad Sci U S A 2001; 98: 2808-13. (Pubitemid 32209565)
134. Wayman GA, Impey S, Marks D, Saneyoshi T, Grant WF, Derkach V, et al. Activity-dependent dendritic arborization mediated by CaM-kinase I activation and enhanced CRE B-dependent transcription of Wnt-2. Neuron 2006; 50: 897-909. (Pubitemid 43850689)
135. T okumitsu H, Inuzuka H, Ishikawa Y, Ikeda M, Saji I, Kobayashi R. STO -609, a specific inhibitor of the Ca2+/calmodulin-dependent protein kinase kinase. J Biol Chem 2002; 277: 15813-8. (Pubitemid 34967859)
136. Yano S, Tokumitsu H, Soderling TR. Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature 1998 396 584-7. (Pubitemid 28563720)
137. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA. The Ca2+/calmodulin-dependent protein kinase kinases are AMPactivated protein kinase kinases. J Biol Chem 2005 280 29060-6. (Pubitemid 41161355)
138. Li J, McCullough LD . Effects of AMP-activated protein kinase in cerebral ischemia. J Cereb Blood Flow Metab 2010 30 480-92.
139. L i J, Benashski SE, Venna VR, McCullough LD. Effects of metformin in experimental stroke. Stroke 2010; 41: 2645-52.
140. Schurr A, Reid KH, Tseng MT, West C, Rigor BM. Adaptation of adult brain tissue to anoxia and hypoxia in vitro. Brain Res 1986; 374: 244-8. (Pubitemid 16077975)
141. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, et al. Ischemic tolerance phenomenon found in the brain. Brain Res 1990; 528: 21-4. (Pubitemid 20292932)
142. Liu Y, Kato H, Nakata N, Kogure K. Protection of rat hippocampus against ischemic neuronal damage by pretreatment with sublethal ischemia. Brain Research 1992 586 121-4.
143. Kirino T. Ischemic tolerance. J Cereb Blood Flow Metab 2002; 22: 1283-96. (Pubitemid 35285085)
144. McCullough LD, Zeng Z, Li H, Landree LE, McFadden J, Ronnett GV. Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J Biol Chem 2005; 280: 20493-502. (Pubitemid 40776749)
145. T u W, Xu X, Peng L, Zhong X, Zhang W, Soundarapandian MM, et al. DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell 2010; 140: 222-34.
146. Zhou L, Li F, Xu HB, Luo CX, Wu HY , Zhu MM, et al. Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95. Nat Med 2010; 16: 1439-43.
147. D erkach V, Barria A, Soderling TR . Ca2+/calmodulin-kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl- 4-isoxazolepropionate type glutamate receptors. Proc Natl Acad Sci U S A 1999; 96: 3269-74. (Pubitemid 29148880)
148. Barria A, Muller D, Derkach V, Griffith LC, Soderling TR. Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation. Science 1997; 276: 2042-5. (Pubitemid 27443609)
149. Oh MC, Derkach VA. Dominant role of the GluR2 subunit in regulation of AMPA receptors by CaMKII. Nat Neurosci 2005 8 853-4.
150. H ollmann M, Hartley M, Heinemann S. Ca2+ permeability of KAAMPA- gated glutamate receptor channels depends on subunit composition. Science 1991; 252: 851-3. (Pubitemid 121000528)
151. Verdoorn T, Burnashev N, Monyer H, Seeburg P, Sakmann, B. Structural determinants of ion flow through recombinant glutamate receptor channels. Science 1991; 252: 1715-8. (Pubitemid 21917095)
152. Liu SJ, Zukin RS. Ca2+-permeable AMPA receptors in synaptic plasticity and neuronal death. Trends Neurosci 2007 30 126-34. (Pubitemid 46283597)
153. Hudmon A, Schulman H, Kim J, Maltez JM, Tsien RW, Pitt GS. CaMKII tethers to L-type Ca2+ channels, establishing a local and dedicated integrator of Ca2+ signals for facilitation. J Cell Biol 2005 171 537-47. (Pubitemid 41586942)
154. Grueter CE, Abiria SA, Dzhura I, Wu Y, Ham AJ, Mohler PJ, et al. L-type Ca2+ channel facilitation mediated by phosphorylation of the beta subunit by CaMKII. Mol Cell 2006; 23: 641-50. (Pubitemid 44292555)
155. Alev C, Urschel S, Sonntag S, Zoidl G, Fort AG, Hoher T, et al. The neuronal connexin36 interacts with and is phosphorylated by CaMKII in a way similar to CaMKII interaction with glutamate receptors. Proc Natl Acad Sci U S A 2008; 105: 20964-9.
156. O guro K, Jover T, Tanaka H, Lin Y, Kojima T, Oguro N, et al. Global ischemia-induced increases in the gap junctional proteins connexin (Cx32) and Cx36 in hippocampus and enhanced vulnerability of Cx32 knock-out mice. J Neurosci 2001; 21: 7534-42.
157. Bargiotas P, Monyer H, Schwaninger, M. Hemichannels in cerebral ischemia. Curr Mol Med 2009; 9: 186-94.
158. Contreras JE, Sanchez HA, Veliz LP, Bukauskas FF, Bennett MV, Saez JC. Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue. Brain Res Brain Res Rev 2004; 47: 290-303. (Pubitemid 39574326)
159. Kan MC, Oruganty-Das A, Cooper-Morgan A, Jin G, Swanger SA, Bassell GJ,
160. Wells DG. RNA-binding proteins: a lesson in repression. J Neurosci 2006; 26: 7135-8.
161. R ichter JD. CPEB: a life in translation. Trends Biochem Sci 2007; 32: 279-85. (Pubitemid 46874928)
162. Wu L, Wells D, Tay J, Mendis D, Abbott MA, Barnitt A, et al. CPEBmediated cytoplasmic polyadenylation and the regulation of experience-dependent translation of [alpha]-camkii mrna at synapses. Neuron 1998; 21: 1129-39. (Pubitemid 29018082)
163. Kundel M, Jones KJ, Shin CY, Wells DG. Cytoplasmic polyadenylation element-binding protein regulates neurotrophin-3-dependent {beta}- catenin mrna translation in developing hippocampal neurons. J Neurosci 2009; 29: 13630-9.
164. L i X, Klaus JA, Zhang J, Xu Z, Kibler KK, Andrabi SA, et al. Contributions of poly(ADP-ribose) polymerase-1 and -2 to nuclear translocation of apoptosis-inducing factor and injury from focal cerebral ischemia. J Neurochem 2010; 113: 1012-22.
165. Komeima K, Hayashi Y, Naito Y, Watanabe Y. Inhibition of neuronal nitric-oxide synthase by calcium/calmodulin-dependent protein kinase II through Ser847 phosphorylation in NG108-15 neuronal cells. J Biol Chem 2000; 275: 28139-43.
166. O suka K, Watanabe Y, Usuda N, Nakazawa A, Fukunaga K, Miyamoto E, et al. Phosphorylation of neuronal nitric oxide synthase at Ser847 by CaM-KII in the hippocampus of rat brain after transient forebrain ischemia. J Cereb Blood Flow Metab 2002; 22: 1098-106. (Pubitemid 35006802)
167. R ameau GA, Chiu LY , Ziff EB. Bidirectional regulation of neuronal nitric-oxide synthase phosphorylation at Serine 847 by the N-methyl- D-aspartate receptor . J Biol Chem 2004; 279: 14307-14. (Pubitemid 38468971)
168. R ameau GA, Tukey DS, Garcin-Hosfield ED , Titcombe RF, Misra C, Khatri L, et al. Biphasic coupling of neuronal nitric oxide synthase phosphorylation to the NMDA receptor regulates AMPA receptor trafficking and neuronal cell death. J Neurosci 2007; 27: 3445-55. (Pubitemid 46515122)
169. D awson V, Kizushi V, Huang P, Snyder S, Dawson T. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthasedeficient mice. J Neurosci 1996; 16: 2479-87. (Pubitemid 26122672)
170. E liasson MJL, Huang Z, Ferrante RJ, Sasamata M, Molliver ME, Snyder SH, et al. Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J Neurosci 1999; 19: 5910-8. (Pubitemid 29327926)
171. Oka M, Hirouchi M, Itoh Y, Ukai Y. Involvement of peroxynitrite and hydroxyradical generated from nitric oxide in hypoxia/reoxygenation injury in rat cerebrocortical slices. Neuropharmacology 2000 39 1319-30. (Pubitemid 30173196)
172. Zhou L, Zhu DY . Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. Nitric Oxide 2009; 20: 223-30.
173. Sessoms-Sikes S, Honse Y, Lovinger DM, Colbran RJ. CaMKIIalpha enhances the desensitization of NR2B-containing NMDA receptors by an autophosphorylation- dependent mechanism. Mol Cell Neurosci 2005; 29: 139-47. (Pubitemid 40603887)
174. Marsden KC, Beattie JB, Friedenthal J, Carroll RC. NMDA receptor activation potentiates inhibitory transmission through GABA receptorassociated protein-dependent exocytosis of GABAA receptors. J Neurosci 2007; 27: 14326-37.
175. Marsden KC, Shemesh A, Bayer KU, Carroll RC. Selective translocation of Ca2+/calmodulin protein kinase IIalpha (CaMKIIalpha) to inhibitory synapses. Proc Natl Acad Sci U S A 2010; 107: 20559-64.
176. Nguyen A, Chen P, Cai H. Role of CaMKII in hydrogen peroxide activation of ERK1/2, p38 MAPK, HSP27 and actin reorganization in endothelial cells. FEBS Lett 2004; 572: 307-13. (Pubitemid 39092554)
177. Wheeler DG, Barrett CF, Groth RD , Safa P, Tsien RW. CaMKII locally encodes L-type channel activity to signal to nuclear CREB in excitation-transcription coupling. J Cell Biol 2008; 183: 849-63.
178. Song B, Lai B, Zheng Z, Zhang Y, Luo J, Wang C, et al. Inhibitory phosphorylation of GSK-3 by CaMKII couples depolarization to neuronal survival. J Biol Chem 2010; 285: 41122-34.
179. Mao Z, Bonni A, Xia F, Nadal-Vicens M, Greenberg ME. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 1999; 286: 785-90.
180. Rudin CM, Thompson CB. Apoptosis and disease: regulation and clinical relevance of programmed cell death. Annu Rev Med 1997 48 267-81. (Pubitemid 27101830)
181. Strasser A, OConnor L, Dixit VM. Apoptosis signaling. Annu Rev Biochem 2000; 69: 217-45.
182. H engartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770-6.
183. H eidenreich KA. Molecular mechanisms of neuronal cell death. Ann NY Acad Sci 2003; 991: 237-250. (Pubitemid 36793818)
184. Wright S, Schellenberger U, Ji L, Wang H, Larrick J. Calmodulindependent protein kinase II mediates signal transduction in apoptosis. FASEB J 1997; 11: 843-9. (Pubitemid 27371893)
185. Fladmark KE, Brustugun OT , Mellgren G, Krakstad C, Boe R, Vintermyr OK, et al. Ca2+/calmodulin-dependent protein kinase ii is required for microcystin-induced apoptosis. J Biol Chem 2002; 277: 2804-11. (Pubitemid 34953312)
186. Krakstad C, Herfindal L, Gjertsen BT, Boe R, Vintermyr OK, Fladmark KE, et al. CaM-kinaseII-dependent commitment to microcystininduced apoptosis is coupled to cell budding, but not to shrinkage or chromatin hypercondensation. Cell Death Differ 2005; 13: 1191-202. (Pubitemid 43905599)
187. Bissonnette SL, Haas A, Mann KK, Schlezinger JJ. The role of CaMKII in calcium-activated death pathways in bone marrow B cells. Toxicol Sci 2010; 118: 108-18.
188. Timmins JM, Ozcan L, Seimon TA, Li G, Malagelada C, Backs J, et al. Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways. J Clin Invest 2009; 119: 2925-41.
189. Fujikawa K, Kawakami A, Tanaka F, Iwamoto N, Tamai M, Eguchi K. Calcium/calmodulin-dependent protein kinase II (CaMKII) regulates tumour necrosis factor-related apoptosis inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells (FLS) by phosphorylation of Akt. Clin Exp Rheumatol 2009; 27: 952-7.
190. Zhu WZ, Wang SQ, Chakir K, Yang D, Zhang T, Brown JH, et al. Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. J Clin Invest 2003; 111: 617-25. (Pubitemid 36278580)
191. Y ang Y, Zhu WZ, Joiner Ml, Zhang R, Oddis CV, Hou Y, et al. Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo. Am J Physiol-Heart Circ Physiol 2006; 291: H3065-75. (Pubitemid 44904109)
192. Sapia L, Palomeque J, Mattiazzi A, Petroff MV. Na+/K+-ATPase inhibition by ouabain induces CaMKII-dependent apoptosis in adult rat cardiac myocytes. J Mol Cell Cardiol 2010; 49: 459-68.
193. Palomeque J, Rueda OV, Sapia L, Valverde CA, Salas M, Petroff MV, et al. Angiotensin II-induced oxidative stress resets the ca2+ dependence of Ca2+-calmodulin protein kinase ii and promotes a death pathway conserved across different species. Circ Res 2009; 105: 1204-12.
194. Peng W, Zhang Y, Zheng M, Cheng H, Zhu W, Cao CM, et al. Cardioprotection by CaMKII-{delta}B is mediated by phosphorylation of heat shock factor 1 and subsequent expression of inducible heat shock protein 70. Circ Res 2010; 106: 102-10.
195. E rickson JR, Joiner ML, Guan X, Kutschke W, Yang J, Oddis CV, et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 2008; 133: 462-74. (Pubitemid 351608692)
196. Vila-Petroff M, Salas MA, Said M, Valverde CA, Sapia L, Portiansky E, et al. CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury. Cardiovas Res 2007; 73: 689-98. (Pubitemid 46227351)
197. Salas MA, Valverde CA, Sánchez G, Said M, Rodriguez JS, Portiansky EL, et al. The signalling pathway of CaMKII-mediated apoptosis and necrosis in the ischemia/reperfusion injury. J Mol Cell Cardiol 2010; 48: 1298-306.
198. Mishra S, Ling H, Grimm M, Zhang T, Bers DM, Brown JH. Cardiac hypertrophy and heart failure development through Gq and Cam kinase II signaling. J Cardiovasc Pharmacol 2010; 56: 598-603.
199. Nutt LK, Margolis SS, Jensen M, Herman CE, Dunphy WG, Rathmell JC, et al. Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2. Cell 2005; 123: 89-103. (Pubitemid 41414531)
200. R okhlin OW, Taghiyev AF, Bayer KU, Bumcrot D, Koteliansk VE, Glover RA, et al. Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survival. Cancer Biol Ther 2007; 6: 732-42. (Pubitemid 47328355)
201. Ma S, Yang Y, Wang C, Hui N, Gu L, Zhong H, et al. Endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest and apoptosis through down-regulation of the phosphatidylinositide 3-kinase/Akt/HDM2 pathway. J Biol Chem 2009; 284: 24773-82.
202. Y ang CS, Thomenius MJ, Gan EC, Tang W, Freel CD, Merritt TJS, et al. Metabolic regulation of Drosophila apoptosis through inhibitory phosphorylation of Dronc. EMBO J 2010; 29: 3196-207.
203. Kajihara R, Fukushige S, Shioda N, Tanabe K, Fukunaga K, Inui S. CaMKII phosphorylates serine 10 of p27 and confers apoptosis resistance to HeLa cells. Biochem Biophys Res Commun 2010; 401: 350-5.
204. T ano JY, Vazquez G. Requirement for non-regulated, constitutive calcium influx in macrophage survival signaling. Biochem Biophys Res Commun 2011; 407: 432-7.
205. Anderson ME, Brown JH, Bers DM. CaMKII in myocardial hypertrophy and hear t failure. J Mol Cell Cardiol 2011. doi: 10.1016/ j.yjmcc.2011.01.012.
206. Srinivasan M, Edman CF, Schulman H. Alternative splicing introduces a nuclear localization signal that targets multifunctional CaM kinase to the nucleus. J Cell Biol 1994; 126: 839-52. (Pubitemid 24252133)
207. L ittle GH, Saw A, Bai Y, Dow J, Marjoram P, Simkhovich B, et al. Critical role of nuclear calcium/calmodulin-dependent protein kinase iideltab in cardiomyocyte survival in cardiomyopathy. J Biol Chem 2009; 284: 24857-68.
208. Ghosh A, Greenberg M. Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 1995; 268: 239-47.
209. Arundine M, Tymianski M. Molecular mechanisms of calciumdependent neurodegeneration in excitotoxicity. Cell Calcium 2003; 34: 325-37. (Pubitemid 37021228)
210. Hardingham GE, Fukunaga Y, Bading H Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 2002 5 405-14. (Pubitemid 34454245)
211. Zhang SJ, Buchthal B, Lau D, Hayer S, Dick O, Schwaninger M, et al. A Signaling cascade of nuclear calcium-CREB-ATF3 activated by synaptic NMDA receptors defines a gene repression module that protects against extrasynaptic NMDA receptor-induced neuronal cell death and ischemic brain damage. J Neurosci 2011; 31: 4978-90.